Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related LJPC
La Jolla Pharmaceutical Shares Mysteriously Rally To New All-Time High
Oppenheimer Is Excited About These 3 Biotech Stocks
La Jolla Pharmaceutical (LJPC) Jumps: Stock Gains 12.3% - Tale of the Tape (Zacks)
Related DRII
Diamond Resorts International Commences Public Offering of 4.833M Shares
Credit Suisse 2015 Outlook On Gaming, Lodging & Leisure

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

Apr 2015OppenheimerInitiates Coverage onOutperform
Mar 2015Chardan CapitalReinstatesBuy
Aug 2014JefferiesInitiates Coverage onBuy

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (LJPC + DRII)

Around the Web, We're Loving...

Get Benzinga's Newsletters